Search for: "Watson Laboratories Inc" Results 61 - 80 of 142
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Mar 2014, 9:31 pm by Patent Docs
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
2 Mar 2014, 8:47 pm by Patent Docs
• Defendants: Watson Laboratories Inc.; Actavis Inc. [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
27 Nov 2013, 6:00 am
This action relates to the Abbreviated New Drug Application ("ANDA") No. 205328 submitted by Watson Laboratories to the U.S. [read post]
17 Nov 2013, 8:56 pm by Patent Docs
• Defendants: Watson Laboratories Inc; Actavis, Inc.; Actavis Pharma, Inc. [read post]
15 Sep 2013, 9:42 pm by Patent Docs
• Defendant: Watson Laboratories Inc. [read post]
10 Jul 2013, 12:00 am
Watson Pharm., Inc. that routine experimentation is "not without bounds. [read post]
16 Jun 2013, 9:32 pm by Patent Docs
Watson Laboratories Inc. et al. 1:13-cv-01015; filed June 6, 2013 in the District Court of Delaware • Plaintiff: Fresenius Kabi USA, LLC • Defendants: Watson Laboratories Inc.; Actavis Inc. [read post]
1 Apr 2013, 8:29 am by Gene Quinn
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
24 Mar 2013, 8:01 pm by Patent Docs
• Defendants: Watson Laboratories, Inc. [read post]
10 Mar 2013, 9:59 pm by Patent Docs
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
11 Feb 2013, 6:44 pm by FDABlog HPM
District Court for the District of Columbia ruled against FDA in a challenge brought by Watson Laboratories, Inc. [read post]
6 Feb 2013, 4:43 pm by Mandour & Associates
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]